<?xml version="1.0" encoding="UTF-8"?>
<p>Clotting and development of coagulopathy appeared as a noxious complication in severe and critical COVID-19 patients [
 <xref rid="B27-jcm-09-01407" ref-type="bibr">27</xref>,
 <xref rid="B70-jcm-09-01407" ref-type="bibr">70</xref>]. Early reports of critically ill patients with coagulopathy showed poor prognostic features. The first hint suggesting that thrombus formation during severe COVID-19 could increase mortality was reported by Zhou et al. [
 <xref rid="B7-jcm-09-01407" ref-type="bibr">7</xref>]. D-dimer levels over 1 Î¼g/L at admission predicted an 18-fold increase in odds of dying among 191 COVID-19 patients. Following several similar reports, the International Society of Thrombosis and Haemostasis promptly proposed an interim guidance on recognition and management of coagulopathy [
 <xref rid="B71-jcm-09-01407" ref-type="bibr">71</xref>].
</p>
